Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HEREDITARY BREAST' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 153 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hurley, KE; Miller, SM; Costalas, JW; Gillespie, D; Daly, MB
      Anxiety/uncertainty reduction as a motivation for interest in prophylacticoophorectomy in women with a family history of ovarian cancer

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    2. Ostrer, H
      A genetic profile of contemporary Jewish populations

      NATURE REVIEWS GENETICS
    3. Randall, J; Butow, P; Kirk, J; Tucker, K
      Psychological impact of genetic counselling and testing in women previously diagnosed with breast cancer

      INTERNAL MEDICINE JOURNAL
    4. Velicer, CM; Taplin, S
      Genetic testing for breast cancer: Where are health care providers in the decision process?

      GENETICS IN MEDICINE
    5. Culver, JO; Hull, JL; Dunne, DFB; Burke, W
      Oncologists' opinions on genetic testing for breast and ovarian cancer

      GENETICS IN MEDICINE
    6. Arver, B; Borg, A; Lindblom, A
      First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm

      GENETIC TESTING
    7. Newman, LA; Kuerer, HM; Hunt, KK; Vlastos, G; Ames, FC; Ross, MI; Singletary, SE
      Educational review: Role of the surgeon in hereditary breast cancer

      ANNALS OF SURGICAL ONCOLOGY
    8. Elit, L; Jack, E; Kwan, E; Baigal, G; Narod, S
      A unique BRCA1 mutation identified in Mongolia

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    9. Eisinger, F; Charafe-Jauffret, E; Jacquemier, J; Birnbaum, D; Julian-Reynier, C; Sobol, H
      Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact

      INTERNATIONAL JOURNAL OF ONCOLOGY
    10. Barkardottir, RB; Sarantaus, L; Arason, A; Vehmanen, P; Bendahl, PO; Kainu, T; Syrjakoski, K; Krahe, R; Huusko, P; Pyrhonen, S; Holli, K; Kallioniemi, OP; Egilsson, V; Kere, J; Nevanlinna, H
      Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families

      EUROPEAN JOURNAL OF HUMAN GENETICS
    11. Bergman, A; Einbeigi, Z; Olofsson, U; Taib, Z; Wallgren, A; Karlsson, P; Wahlstrom, J; Martinsson, T; Nordling, M
      The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation

      EUROPEAN JOURNAL OF HUMAN GENETICS
    12. Bredart, A; Autier, P; Riccardo, A; Audisio, A; Geraghty, JG
      Psychosocial dimensions of BRCA testing: an overshadowed issue

      EUROPEAN JOURNAL OF CANCER CARE
    13. Runnebaum, IB; Wang-Gohrke, S; Vesprini, D; Kreienberg, R; Lynch, H; Moslehi, R; Ghadirian, P; Weber, B; Godwin, AK; Risch, H; Garber, J; Lerman, C; Olopade, OI; Foulkes, WD; Karlan, B; Warner, E; Rosen, B; Rebbeck, T; Tonin, P; Dube, MP; Kieback, DG; Narod, SA
      Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives

      PHARMACOGENETICS
    14. Hirose, K; Tajima, K; Hamajima, N; Takezaki, T; Inoue, M; Kuroishi, T; Miura, S; Tokudome, S
      Association of family history and other risk factors with breast cancer risk among Japanese premenopausal and postmenopausal women

      CANCER CAUSES & CONTROL
    15. Hohenstein, P; Kielman, MF; Breukel, C; Bennett, LM; Wiseman, R; Krimpenfort, P; Cornelisse, G; van Ommen, GJ; Devilee, P; Fodde, R
      A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage

      ONCOGENE
    16. Olopade, OI; Pichert, G
      Cancer genetics in oncology practice

      ANNALS OF ONCOLOGY
    17. Merajver, SD; Milliron, KJ
      Msk of breast and ovarian cancer in women with strong family histories - The Srivastava/McKinnon/Wood article reviewed

      ONCOLOGY-NEW YORK
    18. Meiser, B; Butow, P; Barratt, A; Gattas, M; Gaff, C; Haan, E; Gleeson, M; Dudding, T; Tucker, K
      Risk perceptions and knowledge of breast cancer genetics in women at increased risk of developing hereditary breast cancer

      PSYCHOLOGY & HEALTH
    19. Di Prospero, LS; Seminsky, M; Honeyford, J; Doan, B; Franssen, E; Meschino, W; Chart, P; Warner, E
      Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    20. Eisinger, F; Julian-Reynier, C; Sobol, H
      The prophylactic mastectomy from a medical, individual and social angle

      M S-MEDECINE SCIENCES
    21. Meiser, B; Butow, PN; Barratt, AL; Schnieden, V; Gattas, M; Kirk, J; Gaff, C; Suthers, G; Tucker, K
      Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer

      PATIENT EDUCATION AND COUNSELING
    22. Roy, SK; Trividi, AH; Bakshi, SR; Patel, SJ; Shukla, PS; Shah, AD; Majithiya, DB; Patel, DD; Shah, PM
      A study of chromosome aneuploidy in hereditary breast cancer patients and their healthy blood relatives

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    23. Nicoletto, MO; Donach, M; De Nicolo, A; Artioli, G; Banna, G; Monfardini, S
      BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice andgenetic counselling

      CANCER TREATMENT REVIEWS
    24. Menin, C; Banna, GL; De Salvo, G; Lazzarotto, V; De Nicolo, A; Agata, S; Montagna, M; Sordi, G; Nicoletto, O; Chieco-Bianchi, I; D'Andrea, E
      Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer

      CANCER LETTERS
    25. Ghaderi, A; Talei, A; Farjadian, S; Mosalaei, A; Doroudchi, M; Kimura, H
      Germline BRCA1 mutations in Iranian women with breast cancer

      CANCER LETTERS
    26. Lucchi-Angellier, E
      Patients' rights during medical research, and details of oncology (in France).

      REVUE DE MEDECINE INTERNE
    27. Hofmann, W; Jandrig, B; Classen, E; Nestle-Kraemling, C; Chang-Claude, J; Scherneck, S
      Identification of a recurrent BRCA1 mutation in German breast-cancer and/or ovarian-cancer families

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    28. Chang, J; Elledge, RM
      Clinical management of women with genomic BRCA1 and BRCA2 mutations

      BREAST CANCER RESEARCH AND TREATMENT
    29. Ito, Y; Noguchi, S; Takeda, T; Matsuura, N
      Fas ligand expression in BRCA1-associated hereditary breast carcinoma clearly differs from that in sporadic breast carcinoma

      BREAST CANCER RESEARCH AND TREATMENT
    30. Daly, MB; Barsevick, A; Miller, SM; Buckman, R; Costalas, J; Montgomery, S; Bingler, R
      Communicating genetic test results to the family: A six-step, skills-building strategy

      FAMILY & COMMUNITY HEALTH
    31. Schorge, JO; Mahoney, NM; Miller, DS; Coleman, RL; Muller, CY; Euhus, DM; Tomlinson, GE
      Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer

      GYNECOLOGIC ONCOLOGY
    32. Ruiz-Flores, P; Calderon-Garciduenas, AL; Barrera-Saldana, HA
      Breast cancer genetics. BRCA1 and BRCA2: The main susceptibility genes.

      REVISTA DE INVESTIGACION CLINICA
    33. Kiechle, M; Schmutzler, R
      Preventive strategies for hereditary breast cancer pre-disposition

      RADIOLOGE
    34. Pericay, C; Diez, O; Campos, B; Balmana, J; Domenech, M; Lerma, E; Baena, M; Sabate, JM; Gomez, A; Lopez, JJ; Baiget, M; Alonso, C
      Clinical and pathological characteristics and follow-up of patients with breast cancer and BRCA1/BRCA2 mutations

      MEDICINA CLINICA
    35. Dagan, E; Gershoni-Baruch, R
      Hereditary breast/ovarian cancer - pitfalls in genetic counseling

      CLINICAL GENETICS
    36. Davis, JW; Lauer, FT; Burdick, AD; Hudson, LG; Burchiel, SW
      Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: Correlation with increased transforming growth factoralpha production

      CANCER RESEARCH
    37. Julian-Reynier, CM; Bouchard, LJ; Evans, DG; Eisinger, FA; Foulkes, WD; Kerr, B; Blancquaert, IR; Moatti, JP; Sobol, HH
      Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another - Differences among English, French, and Canadian women

      CANCER
    38. Elit, L
      Familial ovarian cancer

      CANADIAN FAMILY PHYSICIAN
    39. Lasset, C; Bonadona, V
      Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screening

      BULLETIN DU CANCER
    40. Casadei, S; Cortesi, L; Pensotti, V; Radice, P; Pierotti, M; Amadori, D; Calistri, D
      Detection of germline BRCA1 mutations by multiple-dye cleavase fragment length polymorphism (MD-CFLP) method

      BRITISH JOURNAL OF CANCER
    41. Allinen, M; Huusko, P; Mantyniemi, S; Launonen, V; Winqvist, R
      Mutation analysis of the CHK2 gene in families with hereditary breast cancer

      BRITISH JOURNAL OF CANCER
    42. Vahteristo, P; Eerola, H; Tamminen, A; Blomqvist, C; Nevanlinna, H
      A probability model for predicting BRCA1 and BRCA2 mutations in breast andbreast-ovarian cancer families

      BRITISH JOURNAL OF CANCER
    43. Rapakko, K; Allinen, M; Syrjakoski, K; Vahteristo, P; Huusko, P; Vahakangas, K; Eerola, H; Kainu, T; Kallioniemi, OP; Nevanlinna, H; Winqvist, R
      Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

      BRITISH JOURNAL OF CANCER
    44. Stefanek, M; Hartmann, L; Nelson, W
      Risk-reduction mastectomy: Clinical issues and research needs

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    45. Neuhausen, SL
      Founder populations and their uses for breast cancer genetics

      BREAST CANCER RESEARCH
    46. Kato, M; Yano, K; Matsuo, F; Saito, H; Katagiri, T; Kurumizaka, H; Yoshimoto, M; Kasumi, F; Akiyama, F; Sakamoto, G; Nagawa, H; Nakamura, Y; Miki, Y
      Identification of Rad51 alteration in patients with bilateral breast cancer

      JOURNAL OF HUMAN GENETICS
    47. Wood, ME; Mullineaux, L; Rahm, AK; Fairclough, D; Wenzel, L
      Impact of BRCA1 testing on women with cancer: A pilot study

      GENETIC TESTING
    48. Grzybowska, E; Zientek, H; Jasinska, A; Rusin, M; Kozlowski, P; Sobczak, K; Sikorska, A; Kwiatkowska, E; Gorniak , L; Kalinowska, E; Utracka-Hutka, B; Wloch, J; Chmielik, E; Krzyzosiak, WJ
      High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer

      HUMAN MUTATION
    49. Armstrong, K; Calzone, K; Stopfer, J; Fitzgerald, G; Coyne, J; Weber, B
      Factors associated with decisions about clinical BRCA1/2 testing

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    50. Cortesi, L; Turchetti, D; Bertoni, C; Bellei, R; Mangone, L; Vinceti, M; Federico, M; Silingardi, V; Ferrari, S
      Comparison between genotype and phenotype identifies a high-risk population carrying BRCAI mutations

      GENES CHROMOSOMES & CANCER
    51. Decruyenaere, M; Evers-Kiebooms, G; Denayer, L; Welkenhuysen, M; Claes, E; Legius, E; Demyttenaere, K
      Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling

      EUROPEAN JOURNAL OF HUMAN GENETICS
    52. Hofferbert, S; Worringen, U; Backe, J; Ruckert, EM; White, K; Faller, H; Grimm, T; Caffier, H; Chang-Claude, J; Weber, BHF
      Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: First experiences with patient perceptions, surveillance behaviorand acceptance of genetic testing

      GENETIC COUNSELING
    53. Gershoni-Baruch, R; Dagan, E; Fried, G; Bar-Sade, RB; Sverdlov-Shiri, R; Zelicksson, G; Friedman, E
      Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

      EUROPEAN JOURNAL OF CANCER
    54. Sakorafas, GH; Tsiotou, AG
      Prophylactic mastectomy; evolving perspectives

      EUROPEAN JOURNAL OF CANCER
    55. Ozdag, H; Tez, M; Sayek, I; Muslumanoglu, M; Tarcan, O; Icli, F; Ozturk, M; Ozcelik, T
      Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients

      EUROPEAN JOURNAL OF CANCER
    56. Turchetti, D; Cortesi, L; Federico, M; Bertoni, C; Mangone, L; Ferrari, S; Silingardi, V
      BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer

      EUROPEAN JOURNAL OF CANCER
    57. Klemp, J; Brady, D; Frank, TS; Kimler, BF; Fabian, CJ
      Incidence of BRCA1/2 germ line alterations in a high risk cohort participating in a phase II chemoprevention trial

      EUROPEAN JOURNAL OF CANCER
    58. Mixon, M; Kittrell, F; Medina, D
      Expression of Brca1 and splice variant Brca1 Delta 11 RNA levels in mouse mammary gland during normal development and tumorigenesis

      ONCOGENE
    59. Escher, M; Sappino, AP
      Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition

      ANNALS OF ONCOLOGY
    60. Diez, O; Cortes, J; Domenech, M; Pericay, C; Brunet, J; Alonso, C; Baiget, M
      BRCA2 germ-line mutations in Spanish male breast cancer patients

      ANNALS OF ONCOLOGY
    61. Dorval, M; Patenaude, AF; Schneider, KA; Kieffer, SA; DiGianni, L; Kalkbrenner, KJ; Bromberg, JI; Basili, LA; Calzone, K; Stopfer, J; Weber, BL; Garber, JE
      Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs

      JOURNAL OF CLINICAL ONCOLOGY
    62. Ashida, A; Fukutomi, T; Tsuda, H; Akashi-Tanaka, S; Ushijima, T
      Atypical medullary carcinoma of the breast with cartilaginous metaplasia in a patient with a BRCA1 germline mutation

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    63. Julian-Reynier, C; Bourret, P; Sevilla, C; Eisinger, F; Sobol, H; Moatti, JP
      The new genome consumers

      BIOFUTUR
    64. Hofmann, W; Schlag, PM
      BRCA1 and BRCA2 - breast cancer susceptibility genes

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    65. Meiser, B; Butow, P; Barratt, A; Friedlander, M; Kirk, J; Gaff, C; Haan, E; Aittomaki, K; Tucker, K
      Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    66. Donovan, KA; Tucker, DC
      Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample

      JOURNAL OF BEHAVIORAL MEDICINE
    67. Julian-Reynier, C; Eisinger, F; Chabal, F; Lasset, C; Nogues, C; Stoppa-Lyonnet, D; Vennin, P; Sobol, H
      Disclosure to the family of breast/ovarian cancer genetic test results: Patient's willingness and associated factors

      AMERICAN JOURNAL OF MEDICAL GENETICS
    68. Johnson, KA; Rosenblum-Vos, L; Petersen, GM; Brensinger, JD; Giardiello, FM; Griffin, CA
      Response to genetic counseling and testing for the APC I1307K mutation

      AMERICAN JOURNAL OF MEDICAL GENETICS
    69. Meijers-Heijboer, EJ; Verhoog, LC; Brekelmans, CTM; Seynaeve, C; Tilanus-Linthorst, MMA; Wagner, A; Dukel, L; Devilee, P; van den Ouweland, AMW; van Geel, AN; Klijn, JGM
      Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

      LANCET
    70. Bosompra, K; Flynn, BS; Ashikaga, T; Rairikar, CJ; Worden, JK; Solomon, LJ
      Likelihood of undergoing genetic testing for cancer risk: A population-based study

      PREVENTIVE MEDICINE
    71. Collar, MCD; Molina, PO; Orbaiz, RV; Vicente, RA; Arbiza, PA; Puron, MEC
      Epidemiological characteristics of breast cancer development in pre and postmenopausal women

      MEDICINA CLINICA
    72. Meiser, B; Gleeson, MA; Tucker, KM
      Psychological impact of genetic testing for adult onset disorders - An update for clinicians

      MEDICAL JOURNAL OF AUSTRALIA
    73. Lal, G; Liu, G; Schmocker, B; Kaurah, P; Ozcelik, H; Narod, SA; Redston, M; Gallinger, S
      Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16, BRCA1, and BRCA2 mutations

      CANCER RESEARCH
    74. Fricker, JP; Muller, D; Cutuli, B; Rodier, JF; Janser, JC; Jung, GM; Mors, R; Petit, T; Haegele, P; Abecassis, J
      Germ-line mutations at BRCA1 in northeastern France

      BULLETIN DU CANCER
    75. Peelen, T; van Vliet, M; Bosch, A; Bignell, G; Vasen, HFA; Klijn, JGM; Meijers-Heijboer, H; Stratton, M; van Ommen, GJB; Cornelisse, CJ; Devilee, P
      Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families

      BRITISH JOURNAL OF CANCER
    76. Gorski, B; Byrski, T; Huzarski, T; Jakubowska, A; Menkiszak, J; Gronwald, J; Pluzanska, A; Bebenek, M; Fischer-Maliszewska, L; Grzybowska, E; Narod, SA; Lubinski, J
      Founder mutations in the BRCA1 gene in polish families with breast-ovariancancer

      AMERICAN JOURNAL OF HUMAN GENETICS
    77. Eisinger, F; Juliain-Reynier, C; Sobol, H
      Re: Biologic characteristics of interval and screen-detected breast cancers

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    78. Hung, J; Mims, B; Lozano, G; Strong, L; Harvey, C; Chen, TTY; Stastny, V; Tomlinson, G
      TP53 mutation and haplotype analysis of two large African American families

      HUMAN MUTATION
    79. Sellers, TA; Walsh, AJ; Grabrick, DM; Anderson, KE; Cerhan, JR; Folsom, AR
      Family history, ethnicity, and relative risk of breast cancer in a prospective cohort study of older women

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    80. Codori, AM; Petersen, GM; Miglioretti, DL; Larkin, EK; Bushey, MT; Young, C; Brensinger, JD; Johnson, K; Bacon, JA; Booker, SV
      Attitudes toward colon cancer gene testing: Factors predicting test uptake

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    81. Durfy, SJ; Bowen, DJ; McTiernan, A; Sporleder, J; Burke, W
      Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    82. Gershoni-Baruch, R; Dagan, E; Fried, G; Kepten, I; Robinson, E
      BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer

      EUROPEAN JOURNAL OF HUMAN GENETICS
    83. Shen, DJ; Vadgama, JV
      BRCA1 and BRCA2 gene mutation analysis: Visit to the Breast Cancer Information Core (BIC)

      ONCOLOGY RESEARCH
    84. Dorum, A; Hovig, E; Trope, C; Inganas, M; Moller, P
      Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA

      EUROPEAN JOURNAL OF CANCER
    85. Daly, M
      NCCN practice guidelines: Genetics/familial high-risk cancer screening

      ONCOLOGY-NEW YORK
    86. Bluman, LG; Rimer, BK; Berry, DA; Borstelmann, N; Iglehart, JD; Regan, K; Schildkraut, J; Winer, EP
      Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2

      JOURNAL OF CLINICAL ONCOLOGY
    87. Phillips, KA; Andrulis, IL; Goodwin, PJ
      Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: Are they prognostically different?

      JOURNAL OF CLINICAL ONCOLOGY
    88. Carter, CL; Hailey, BJ
      Psychological issues in genetic testing for breast cancer

      WOMEN & HEALTH
    89. Schuyer, M; Berns, EMJJ
      Is TP53 dysfunction required for BRCA1-associated carcinogenesis?

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    90. Sobol, H; Bignon, YJ; Bonaiti, C; Cuisenier, J; Lasset, C; Lortholary, A; Nogues, C; Stoppa-Lyonnet, D; Eisinger, F
      Four years analysis of cancer genetic clinics activity in France from 1994to 1997: A survey on 801 patients

      DISEASE MARKERS
    91. Reichelt, JG; Dahl, AA; Heimdal, K; Moller, P
      Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations

      DISEASE MARKERS
    92. Jernstrom, HCB; Johannsson, OT; Loman, N; Borg, A; Olsson, H
      Reproductive factors in hereditary breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    93. Federico, M; Maiorana, A; Mangone, L; Turchetti, D; Canossi, B; Cortesi, L; Romagnoli, R; Silingardi, V
      Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal

      BREAST CANCER RESEARCH AND TREATMENT
    94. Yang, XH; Lippman, ME
      BRCA1 and BRCA2 in breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    95. Ondrusek, N; Warner, E; Goel, V
      Development of a knowledge scale about breast cancer and heredity (BCHK)

      BREAST CANCER RESEARCH AND TREATMENT
    96. Garber, J
      A 40-year-old woman with a strong family history of breast cancer

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    97. Backe, J; Hofferbert, S; Skawran, B; Dork, T; Stuhrmann, M; Karstens, JH; Untch, M; Meindl, A; Burgemeister, R; Chang-Claude, J; Weber, BHF
      Frequency of BRCA1 mutation 5382insC in German breast cancer patients

      GYNECOLOGIC ONCOLOGY
    98. Gauthier-Villars, M; Gad, S; Caux, V; Pages, S; Blandy, C; Stoppa-Lyonnet, D
      Genetic testing for breast cancer predisposition

      SURGICAL CLINICS OF NORTH AMERICA
    99. van Golen, K; Milliron, K; Davies, S; Merajver, SD
      BRCA-associated cancer risk: Molecular biology and clinical practice

      JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    100. Eisinger, F; Nogues, C; Guinebretiere, JM; Peyrat, JP; Bardou, VJ; Noguchi, T; Vennin, P; Sauvin, R; Lidereau, R; Birnbaum, D; Jacquemier, J; Sobol, H
      Novel indications for BRCA1 screening using individual clinical and morphological features

      INTERNATIONAL JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 03:47:41